180 Life Sciences Corp. (NASDAQ: ATNF)
$1.9600
+0.0200 ( -1.01% ) 32.1K
180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy.
Market Data
Open
$1.9600
Previous close
$1.9400
Volume
32.1K
Market cap
$3.91M
Day range
$1.8160 - $2.1900
52 week range
$1.1600 - $17.7500
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 15 | Jul 30, 2024 |
| 8-k | 8K-related | 15 | Jul 23, 2024 |
| 8-k | 8K-related | 15 | Jul 02, 2024 |
| 8-k | 8K-related | 14 | May 21, 2024 |
| 10-q | Quarterly Reports | 62 | May 15, 2024 |
| 8-k | 8K-related | 14 | May 15, 2024 |
| 8-k | 8K-related | 20 | May 09, 2024 |
| 10-k/a | Quarterly Reports | 17 | Apr 29, 2024 |
| 8-k | 8K-related | 17 | Apr 19, 2024 |
| 10-k | Annual reports | 101 | Mar 25, 2024 |